🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT06981663
Recruiting Observational

Effects of Fibres Combined With Probiotics on Uric Acid in an ex Vivo Fermentation Model

NCT06981663 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2025-06-12
Last updated
2025-08-12

Condition(s) studied

Hyperuricemia

Study summary

In this study, we will collect faecal samples from individuals with hyperuricaemia (assessed by blood test) and perform in vitro faecal fermentation studies to assess how probiotics in combination with fibres affect urate metabolism in these faecal samples.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Signed informed consent prior to any study-related procedures 2. Age 18-80 years old 3. BMI range 18.5-35 kg/m2 4. Blood uric acid above 0.36 mmol/L (6 mg/dl) 5. Willing to abstain from regular consumption of probiotic supplements or food products containing probiotic bacteria (including fermented food and beverages), until collection of faecal material 6. Willing to abstain from regular consumption of supplements and medications known to alter gastrointestinal function or inflammatory status during the study, until collection of faecal material Exclusion Criteria: 1. Diagnosis of type 1 and/or type 2 diabetes 2. Diagnosed inflammatory bowel disease (IBD) 3. Current diagnosis of psychiatric disease/s or syndromes 4. Current diagnosis of neurodegenerative disease 5. Current pregnancy or breastfeeding 6. History of complicated gastrointestinal surgery 7. Systemic use of antibiotics and/or steroid medication in the last 4 months prior to inclusion 8. Regular use of any non-steroidal anti-inflammatory drug (NSAID) for the last 2 months 9. Consumption of any NSAID within 3 days of sample collection 10. Current (or within the last 4 weeks prior to study start) use of probiotic supplementation 11. Any condition or intake of medication which could substantially interfere with the outcome of the study, as decided by the principal investigator's discretion 12. After being included in the study and until collection of faecal material, starting any medication or treatment that could potentially influence the study participation and/or study analysis

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Örebro University Örebro Sweden Recruiting

More Örebro University, Sweden trials in Sweden

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06981663 on ClinicalTrials.gov ↗ ← All trials in Sweden